Enterobacteriaceae

"Enterobacteriaceae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.

Descriptor ID	D004755
MeSH Number(s)	B03.440.450.425 B03.660.250.150
Concept/Terms	Enterobacteriaceae Enterobacteriaceae Enterobacteria Coliform Bacilli Sodalis Sodalis Paracolobactrum Paracolobactrum Ewingella Ewingella Leclercia Leclercia

Below are MeSH descriptors whose meaning is more general than "Enterobacteriaceae".

Organisms [B]
Bacteria [B03]
Gram-Negative Bacteria [B03.440]
Gram-Negative Facultatively Anaerobic Rods [B03.440.450]
Enterobacteriaceae [B03.440.450.425]
Proteobacteria [B03.660]
Gammaproteobacteria [B03.660.250]
Enterobacteriaceae [B03.660.250.150]

Below are MeSH descriptors whose meaning is more specific than "Enterobacteriaceae".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Enterobacteriaceae" by people in this website by year, and whether "Enterobacteriaceae" was a major or minor topic of these publications.

Bar chart showing 55 publications over 22 distinct years, with a maximum of 7 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	0	1
1999	0	1	1
2001	2	1	3
2003	3	0	3
2004	0	2	2
2005	1	0	1
2006	1	1	2
2007	1	0	1
2008	1	1	2
2009	0	1	1
2011	1	0	1
2015	3	2	5
2016	5	1	6
2017	4	1	5
2018	7	0	7
2019	1	2	3
2020	1	0	1
2021	1	1	2
2023	0	3	3
2024	1	2	3
2025	0	1	1

Below are the most recent publications written about "Enterobacteriaceae" by people in Profiles.

DeRyke CA, Wise MG, Bauer KA, Siddiqui F, Young K, Motyl MR, Sahm DF. Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).

View in: PubMed
Karlowsky JA, Wise MG, Hackel MA, Six DA, Uehara T, Daigle DM, Pevear DC, Moeck G, Sahm DF. Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22. J Antimicrob Chemother. 2024 12 02; 79(12):3116-3131.

View in: PubMed
Karlowsky JA, Lob SH, Hawser SP, Kothari N, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021. Eur J Clin Microbiol Infect Dis. 2024 Jul; 43(7):1343-1348.

View in: PubMed
Wise MG, Karlowsky JA, Mohamed N, Hermsen ED, Kamat S, Townsend A, Brink A, Soriano A, Paterson DL, Moore LSP, Sahm DF. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022. J Glob Antimicrob Resist. 2024 06; 37:168-175.

View in: PubMed
Wise MG, Karlowsky JA, Mohamed N, Kamat S, Sahm DF. In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. Eur J Clin Microbiol Infect Dis. 2023 Sep; 42(9):1135-1143.

View in: PubMed
Karlowsky JA, Wise MG, Hsieh TC, Lu HC, Chen WT, Cheng MH, Siddiqui F, Young K, Motyl MR, Sahm DF. Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021. J Glob Antimicrob Resist. 2023 09; 34:106-112.

View in: PubMed
Karlowsky JA, Hackel MA, Stone GG, Sahm DF. In Vitro Activity of Ceftibuten-Avibactam against ?-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0134622.

View in: PubMed
Karlowsky JA, Kazmierczak KM, Valente MLNF, Luengas EL, Baudrit M, Quintana A, Irani P, Stone GG, Sahm DF. In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019. Braz J Infect Dis. 2021 Nov-Dec; 25(6):101647.

View in: PubMed
Karlowsky JA, Lob SH, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019. BMC Microbiol. 2021 03 06; 21(1):74.

View in: PubMed
Lob SH, Karlowsky JA, Young K, Motyl MR, Hawser S, Kothari ND, Sahm DF. In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017. J Med Microbiol. 2020 Feb; 69(2):207-217.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement